Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity
- 31 July 1993
- journal article
- research article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 19 (3), 197-228
- https://doi.org/10.1016/0305-7372(93)90036-q
Abstract
No abstract availableThis publication has 63 references indexed in Scilit:
- Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinomaEuropean Journal Of Cancer, 1992
- Activity of high-dose epirubicin in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Weekly low dosage epirubicin in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Current Status of Epirubicin (Farmorubicin) in the Treatment of Solid TumoursActa Oncologica, 1990
- Effective palliation of advanced breast cancer with weekly low dose epirubicinEuropean Journal of Cancer and Clinical Oncology, 1989
- Advanced Breast Cancer: A randomised trial of epidoxorubicin at two different dosages and two administration systemsActa Oncologica, 1989
- Absorption of epi-doxorubicin after intravesical administration of patients with in situ transitional cell carcinoma of the bladderEuropean Journal of Cancer and Clinical Oncology, 1987
- Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moietyChemico-Biological Interactions, 1977
- Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinoneJournal of Medicinal Chemistry, 1975